AT

Alan Taylor

Clarity Pharmaceuticals Ltd | Executive Chairman, Executive Director
Dr Taylor has been instrumental in shaping Claritys growth and strategy and has been closely involved across all areas of the Groups business. He has more than 15 years of investment banking experience, with a particular focus on the life sciences sector. He has significant expertise in capital raisings, mergers and acquisitions, and general corporate advisory and has been involved in approximately 2 billion of transactions prior to joining Clarity. Before joining Clarity, he was an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank.

Company and Roles

Company
Title
Tenure
Since
CU6
Clarity Pharmaceuticals Ltd
  • Executive Chairman
  • Executive Director
12yrs, 10mthNov 2013

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CU6
Clarity Pharmaceuticals Ltd
30/06/262,219,15114,066,6604,851,793N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CU6
Clarity Pharmaceuticals Ltd
25/11/25
Issued
1,262,838$1.616$2,041,200Issue of options
CU6
Clarity Pharmaceuticals Ltd
01/07/25
Exercise
1,000,000$0.938$937,500Exercise of options
CU6
Clarity Pharmaceuticals Ltd
01/07/25
Buy
592,373$1.583$937,500Exercise of options
CU6
Clarity Pharmaceuticals Ltd
20/11/24
Issued
740,748$2.756$2,041,200Issue of options
CU6
Clarity Pharmaceuticals Ltd
01/10/24
Buy
1,083,776$0.913$990,000Exercise of options